Arteris, Inc. (AIP) · Aug 6, 2026 · Company update

Revenue beat guidance and full-year outlook rose, but margins weakened

Revenue beat guidance and full-year outlook rose, but margins weakened

The quarter landed modestly above the standing bar on revenue. The prior company outlook called for Q2 revenue of $23–$24 million, while the published consensus was roughly $23.5 million; reported revenue was $24.1 million, a narrow beat.

MetricQ2 2026Q2 2025 / prior expectationRead
Revenue$24.1M$16.5M; prior guide $23–$24MAbove guide midpoint (Income Statement; Financial Guidance)
Non-GAAP operating loss$(4.6)M$(3.5)MLoss widened year over year and was worse than the prior $2–$3M guide (Non-GAAP Reconciliation)
Non-GAAP EPS$(0.10)$(0.11); published consensus about $(0.04)Improved year over year, but below consensus (Non-GAAP EPS Reconciliation)
Non-GAAP gross margin87%91%Down 4 percentage points (Non-GAAP Reconciliation)
Free cash flow$8.6M$(2.8)MSharp improvement (Free Cash Flow Reconciliation)

The more important forward signal was a revenue-guidance raise. Full-year revenue guidance moved to $95–$98 million from the previous $91–$95 million range, while ACV plus royalties guidance was set at $102–$106 million; Q3 revenue is guided to $24–$25 million. That is a meaningful improvement in the top-line outlook, not merely a confirmation of the prior plan (Financial Guidance).

Profitability was the clear offset. Revenue grew 46% year over year, but GAAP operating expenses rose 50%, including $2.2 million of acquisition-related costs, while non-GAAP operating loss increased to $4.6 million from $3.5 million. Gross margin also fell to 85% GAAP and 87% non-GAAP from 89% and 91%, respectively, suggesting the growth came with weaker near-term economics (Income Statement; Non-GAAP Reconciliation).

Liquidity improved, but largely because of equity financing rather than operations. Arteris ended June with $93.3 million of cash and $28.8 million of short-term investments, versus $33.9 million and $20.7 million at year-end. However, $72.5 million of that cash increase came from the at-the-market stock offering, and shares outstanding rose to 49.1 million from 44.3 million (Balance Sheet; Cash Flow statement). Operating cash flow was positive at $9.2 million in Q2, but dilution materially changes the quality of the balance-sheet improvement.

Net: a narrow positive versus expectations. The revenue beat, stronger design activity, and higher full-year revenue outlook outweigh the weaker margin and operating-loss performance, but the result is not a clean beat: the company raised growth expectations while falling short on earnings quality and relying heavily on new equity capital.

Original filing on SEC EDGAR

More Arteris, Inc. news

Revenue beat guidance and full-year outlook rose, but margins weakened | AIP Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.